GI Neuromuscular Pathology Prospective Registry for Gastroparesis
This observational study is collecting biopsy samples from your stomach and/or small intestine (proximal jejunum) to better understand the causes of gastroparesis (a condition where your stomach empties too slowly, causing nausea, bloating, and fullness). Researchers hope these samples will help predict how well gastric electrical stimulation (GES) might work for you. You can join if you are between 6 months and 90 years old and are having surgery for a gastrointestinal (GI) neuromuscular disorder or other digestive system surgeries. The study is looking at how biological markers in the biopsies predict outcomes of GES up to 6 months after the procedure. The current recruitment status is unclear.
- Study design
- This is an observational study with a planned enrollment of 300 participants. It includes a study group of patients with gastroparesis and a control group of patients undergoing other digestive system surgeries.
- What's involved
- If you have gastroparesis, you will complete two questionnaires and have follow-up clinic visits at 6, 12, 18, and 24 months after your GES implantation. All participants will have a surgical full thickness biopsy during their planned surgery.
- Compensation
- Not stated in the trial record.
- Follow-up
- If you are in the study group, you will be followed in the clinic at 6, 12, 18, and 24 months post-implantation.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
GI Neuromuscular Pathology Prospective Registry
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- John M Wo, MD · PRINCIPAL_INVESTIGATOR · Indiana University
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Biologic Markers As Predictors for Gastric Electrical Stimulation Outcomesfrom implantation to 6 months after
To determine if ICC abnormalities of the stomach and proximal jejunum can be used as a biologic marker in predicting clinical outcome in patients undergoing surgical implantation of gastric electrical stimulation (GES) for severe gastroparesis.